Showing results (1-10 of 71) with videos related to
Sort By:
Pageof 8
Current Treatment Options in Oncology|July 23, 2018
Maintenance Therapy in Diffuse Large B Cell Lymphoma and Mantle Cell LymphomaBrian G TillHead & Neck|November 6, 2007
Response to paclitaxel in adenoid cystic carcinoma of the salivary glandsBrian G Till, Renato G MartinsImmunotherapy|May 31, 2012
Depletion of Tregs for adoptive T-cell therapy using CD44 and CD137 as selection markersBrian G Till, Oliver W PressExpert Opinion on Biological Therapy|September 3, 2009
Treatment of lymphoma with adoptively transferred T cellsBrian G Till, Oliver W PressCancer Letters|July 10, 2016
Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapyHamid Reza Mirzaei, Hamed Mirzaei, Sang Yun Lee, et al.Journal of Cellular Physiology|October 15, 2018
Predictive and therapeutic biomarkers in chimeric antigen receptor T-cell therapy: A clinical perspectiveHamid Reza Mirzaei, Hamed Mirzaei, Afshin Namdar, et al.Frontiers in Oncology|November 15, 2021
Toxic Epidermal Necrolysis-Like Reaction Following Combination Therapy With Camrelizumab and Apatinib for Advanced Gallbladder CarcinomaYonghao Yang, Jun Li, Brian G Till, et al.Blood Cancer Discovery|September 27, 2021
Scalable Manufacturing of CAR T cells for Cancer ImmunotherapyMohamed Abou-El-Enein, Magdi Elsallab, Steven A Feldman, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membraneScott E James, Philip D Greenberg, Michael C Jensen, et al.Blood Research|October 13, 2018
Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphomaAdam M Greenbaum, Damian J Green, Leona A Holmberg, et al.Pageof 8